SNCA and Parkinson disease: LevoDopa's altered metabolism in PD patients governs the deleterious feedbacks between the main pathogenic axes, including mitochondrial dysfunction, toxic metabolites, proteasome alteration and alpha‐synuclein aggregation, thus turning the PD cure into a curse in disguise.5